Capital Research Global Investors Dexcom Inc Call Options Transaction History
Capital Research Global Investors
- $463 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DXCM
# of Institutions
1,013Shares Held
351MCall Options Held
5.51MPut Options Held
5.6M-
Vanguard Group Inc Valley Forge, PA47.4MShares$3.6 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.62 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.26 Billion0.05% of portfolio
-
Baillie Gifford & CO15MShares$1.14 Billion0.77% of portfolio
-
Sands Capital Management, LLC Arlington, VA10.3MShares$783 Million2.2% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $29.3B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...